Jacobs Levy Equity Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-491
| Closed | -$62K | – | 1061 |
|
|
2018
Q4 | $62K | Buy |
491
+127
| +35% | +$16K | ﹤0.01% | 952 |
|
|
2018
Q3 | $149K | Sell |
364
-47
| -11% | -$19.2K | ﹤0.01% | 951 |
|
|
2018
Q2 | $222K | Sell |
411
-346
| -46% | -$187K | ﹤0.01% | 936 |
|
|
2018
Q1 | $348K | Buy |
757
+323
| +74% | +$148K | 0.01% | 839 |
|
|
2017
Q4 | $291K | Buy |
+434
| New | +$291K | 0.01% | 850 |
|
|
2017
Q3 | – | Sell |
-258
| Closed | -$124K | – | 1028 |
|
|
2017
Q2 | $124K | Buy |
258
+170
| +193% | +$81.7K | ﹤0.01% | 885 |
|
|
2017
Q1 | $66K | Sell |
88
-56
| -39% | -$42K | ﹤0.01% | 884 |
|
|
2016
Q4 | $141K | Sell |
144
-36
| -20% | -$35.3K | ﹤0.01% | 864 |
|
|
2016
Q3 | $240K | Sell |
180
-6
| -3% | -$8K | ﹤0.01% | 860 |
|
|
2016
Q2 | $162K | Buy |
+186
| New | +$162K | ﹤0.01% | 1045 |
|